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A 72kD trophoblast glycoprotein defined by a monoclonal antibody
N. Hole & P.L. Stern
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Summary A novel trophoblast cell surface antigen has been defined by a monoclonal antibody 5T4, raised
following immunisation with wheat germ agglutinin (WGA) purified glycoproteins from deoxycholate (DOC)
solubilised human syncytiotrophoblast plasma membrane (StMPM). The distribution of the antigen was
determined by indirect immunoperoxidase staining of sections of normal organ and placental tissues as well as
immunofluorescence and radiobinding assays with a wide variety of cell lines representing differing normal
and tumour cell types. In frozen sections of normal full term placenta, 5T4 is strongly expressed only by the
syncytiotrophoblast, some extravillous cytotrophoblast and the amniotic epithelium. The 5T4 antigen is
apparently not expressed by any maternal component of the placenta nor is it detected in adult liver, lung,
bronchus, heart, testis, ovary, brain, or muscle. The antigen is apparently expressed by several specialised
epithelia. Immunoprecipitation of radiolabelled StMPM indicated that 5T4 molecules are glycoproteins of
mol. wt of -72kD on SDS-PAGE. 5T4 antigen is selectively expressed by diverse tumour cell lines, including
those of developmental origin. The molecular characteristics, relatively restricted normal tissue distribution
and expression by certain tumour cell types make this antigen worthy of future study for use as a diagnostic
marker of malignancy.
Trophoblast demonstrates some functional properties of
neoplastic tissue, viz. invasiveness of host tissue and escape
from immunological surveillance. Several monoclonal
antibodies to trophoblast membrane proteins have been
described. In terms of cancer research, the rationale behind
this approach has been to identify 'oncofoetal' antigens
present on both trophoblast and neoplastic cells (Johnson,
1984). If such antigens were restricted to neoplastic tissues,
then these reagents would be potentially useful in diagnosis,
tumour localisation and drug targeting. Of those monoclonal
antibodies that do identify trophoblast oncofoetal antigens,
relatively few have been fully characterised. A variety of
monoclonal antibodies have been shown to be reactive with
the placental alkaline phosphatase (PLAP), and these have
shown the greatest clinical potential (McLaughlin, 1986).
The low level of PLAP in normal non-pregnant sera, and
restricted tissue distribution has been useful in monitoring
some ovarian carcinomas by a serum assay (McDicken et al.,
1985) and radio-imaging (Epenetos et al., 1985; Critchley et
al., 1986). However, PLAP-reactive monoclonal antibodies
are not reactive with all ovarian carcinomas. Clearly there is
a place for further reagents against different molecular
species which show a different and/or wider tumour cell type
reactivity. Here we describe a novel trophoblast antigen
which is also expressed by some tumour cell lines.
Materials and methods
Purification ofsyncytiotrophoblast glycoproteins
StMPM was purified from full term human placentae,
obtained within I h post partum, by the method of Smith et
al. (1974). The StMPM pellet was solubilised in 0.5% DOC
in tris-buffered saline (TBS, 0.15 M NaCl, 25mM tris, pH8.0)
containing 0.1 mM phenylsulphonylmethyl fluoride (PMSF)
and centrifuged at 14,000g for 10min. The WGA-reactive
glycoproteins were then purified by incubation of the super-
natant with WGA-Sepharose (5mgligandml-1 Sepharose)
for 1 h at room temperature. The beads were washed
extensively in TBS/0.5% DOC, and the specifically bound
glycoproteins eluted in 5ml of 0.2M N-acetyl glucosamine
(Sigma) in TBS. The eluted fraction was extensively dialysed
against 30 mM ammonium bicarbonate (pH 7.9), and
lyophilised.
Generation ofmonoclonal antibody
A male BALB/c mouse was immunised by 6 i.p. injections of
WGA-purified StMPM glycoproteins (100-200,rg/injection).
Spleen cells were fused with NS 1 murine myeloma cells
(Kohler & Milstein, 1975), and the cells plated out in 24 well
Linbro plates at 7 x 105 cells/well. After 2 weeks, wells were
assayed for StMPM reactive antibody by immunodotting.
Positive clones were picked directly and further subcloned by
limiting dilution. The antibody subclass was determined by
double radial diffusion using a monoclonal isotype typing kit
(Serotec, Bicester, UK).
Cell culture
Details of the cell lines are given in Table III. Standard
tissue culture media, alpha Dulbecco's modified Eagle's
medium (DMEM), DMEM or RPMI supplemented with
antibiotics and 10-20% foetal calf serum (Gibco) were used.
Radioactive labelling ofmembranes and cells
Near confluent cell cultures of AV-3 cells were radiolabelled
for 15-18 h with 3H-glucosamine (20 uCiml-1) (Amersham;
International) in RPMI containing 10% dialysed FCS.
Metabolically labelled cells were collected and immuno-
precipitated as follows: cells were removed from tissue
culture flasks by incubation in 0.1 M EGTA-PBS, washed in
PBS (Dulbecco's-A) and then solubilised for 30min at 4°C in
0.5% (v/v) NP40 in tris-buffered saline (TBS, 0.15M NaCl,
25mM Tris, pH 8.0) containing 0.1 mM PMSF. Non-
solubilised cellular components were removed by
centrifugation at 14,000g and the amount of radioactivity
incorporated into protein was determined following precipi-
tation with 10% trichloroacetic acid.
Cell-surface labelling by the lactoperoxidase-1251 method
together with the techniques of immunoprecipitation and
SDS-PAGE were carried out as previously described;
high mol. wt standards (Sigma), red blood cell membrane
proteins or 14C-methylated protein mixtures (Amersham
International) were used as marker proteins (Thompson et
al., 1984; Stern et al., 1984,1986). Tritiated sodium boro-
hydride labelling of cell surface glycoproteins was carried out
as described by Axelsson et al. (1978). Autoradiography and
fluorography were as described in Thompson et al. (1984)
using pre-flashed Fuji X-ray film.
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Immunoperoxidase and immunofluorescence labelling
Immunoperoxidase staining of frozen tissue sections was
carried out by the method of Bulmer & Sunderland (1983).
Tissues were obtained as soon as possible post-mortem,
always within 12h, and processed immediately. Indirect
immunofluoresecence with cell suspensions was as described
previously (Thompson et al., 1984). A monoclonal antibody
generated in this laboratory against a widely expressed
human antigen (mAb 1D2) was used as positive control.
Radiobinding assay ofcell surface antigen expression
Cells were harvested with either EGTA-PBS or
EGTA/trypsin, washed and resuspended in Earle's buffered
saline solution (EBSS) with 0.5% bovine serum albumin and
0.1% sodium azide at 2 x 106 cellsml-1. The suspensions
were plated out at 50,u (105 cells)/well in microtitre plates.
Fifty ,ul mAb/well were added and incubated at room
temperature for 1 h. The cells were washed and 5 x 105 CPM
of 1251I-labelled (Fab')2 fragments of sheep anti-murine
immunoglobulin (Amersham International) added. Following
incubation for 1 h at room temperature, the cells were
washed, harvested, and bound radioactivity determined on a
gamma-counter. Assays were carried out in quadruplicate.
Results are expressed as a ratio of specifically bound
radioactive cpm relative to CPM with negative control
antibodies. In some experiments 107 cells were incubated
with 1 ml of fixative (buffered 10% formalin, Bouins'
fixative, 0.25% gluteraldehyde, absolute ethanol or PBS
control) for 30min at room temperature and washed in
EBSS. After incubation in 0.5% BSA in EBSS for 30min,
the cells were then processed as described above.
Preparation ofcrude membranefrom normal human tissues
Tissues were obtained within 12h of death, and processed
immediately. Tissue (10-20g) was finely chopped, rinsed,
and homogenised in 10-20ml of ice-cold PBS containing
5 mM MgCl2 and 0.1 mM PMSF with 20 strokes of a Dounce
homogeniser. The homogenate was centrifuged at 10,000g
for 20min, the pellet discarded and the supernatant
centrifuged at 100,000g for 1 h. This pellet was solubilised in
0.5% (w/v) DOC/TBS containing 0.1 mM PMSF and un-
solubilised material pelleted by centrifugation at 14,000g.
The protein concentration of the supernatant was determined
by the method of Lowry et al. (1951). Membranes from 12h
old placentae were prepared identically and acted as positive
controls.
Gelfiltration
StMPM protein (50mg) was solubilised in 6.5ml of 1.0%
(w/v) DOC/TBS containing 0.1 mM PMSF, centrifuged at
100,000g for 30 min, and the supernatant fractionated over
S200 Sephacryl (Pharmacia). Column size was 90 x 2 cm,
running buffer was 0.1% (w/v) NaDOC/TBS containing
0.1 mM PMSF. Flow rate was 17 ml h- 1. Fraction size was
3.3ml. The column was calibrated with the following
proteins; Equine ferritin (Sigma), IgG (Kabi), transferrin
(Sigma), Bovine serum albumin (Sigma) and ovalbumin
(Sigma). Fractions were assayed for 5T4 antigen in ELISA
and immunodot.
ELISA and immunodot
ELISA plates (Dynatech) were activated by 1 h incubation
with 100 p1/well of PBS containing 0.25% gluteraldehyde
(BDH), the plates washed with PBS, and 100I1/well of
undiluted or 10-fold diluted fractions from gel filtration
bound to the plates by overnight incubation at 4°C.
Following washing, the plates were incubated with 1%
BSA/TBS as blocking agent. ELISA was then carried out as
described (Johnson et al., 1981). Immunodotting on nitro-
cellulose was carried out using the Bio-Rad Dot-Blot
apparatus. Fractions from gel filtration were loaded at 10pl
and 100pl/dot. NaDOC solubilised plasma membrane was
loaded in the range of 50pg-12.5 ng protein/dot. The
following antigens were loaded at 1 g protein/dot;
transferrin (Sigma), PLAP (gift of Dr P.J. McLaughlin),
human placental lactogen (HPL) (Sigma), calmodulin
(Sigma), IgG (Miles Ltd.), albumin (Miles Ltd.) and normal
human sera. The nitrocellulose sheet was blocked with 3%
(w/v) BSA (Sigma) in TBS and processed as described
previously (Webb et al., 1985). In both ELISA and
immunodot, mAb 1D2 was used as positive control.
Enzymatic digestion
StMPM membranes (- 1 mg protein) were treated overnight
at 37°C with either 2mg trypsin (Boehringer), 2mg pronase
(Boehringer), 0.1U neuraminidase (Behringwerke) in 300p1
PBS or 10Uml-1 N-glycanase (Genzyme) in buffer
containing final concentrations as follows: 0.17% SDS; 0.2M
tris-HCl, pH8.7; 10mM 1,10-phenanthroline hydrate (in
methanol); 1.25% NP-40 (Plummer et al., 1984). The treated
membranes were solubilised in DOC/TBS and 5T4 residual
antigenicity assayed by dot-blot. 5T4 immunoprecipitates of
detergent solubilised '25I-radiolabelled StMPM were eluted
from protein-A-Sepharose with 0.5% SDS in water and
incubated overnight at 37°C with or without 10Uml- N-
glycanase in buffer as above. Digests were subjected to
reduced SDS-PAGE and autoradiography.
Results
The monoclonal antibody 5T4 is a murine IgGl. All work
detailed in this study was carried out using subclone 5T4.B8.
The preliminary screen by immunodot showed that the
antigen recognised was none of the following major proteins
associated with the trophoblast; IgG, transferrin, PLAP,
HPL, albumin, calmodulin, nor was it detectable in serum.
Tissue distribution
5T4 antigen expression in first trimester and full term
placentae was investigated using indirect immunoperoxidase
staining of frozen sections. Figure 1 illustrates antigen
expression in term villous placenta as assessed by immuno-
histology of frozen sections. Villous trophoblast was strongly
labelled by mAb 5T4, whereas the stroma was negative.
There was specific labelling of the amniotic epithelium and
extravillous cytotrophoblast of the chorion laeve but not of
the amniotic mesenchyme or maternal decidua (Figure lc,d).
Appropriate positive and negative controls are also shown;
mAb 1D2 labelled all parts of villi (Figure la), mAb H316
labelled trophoblast but was not specific for this tissue type
(Figure lb; Stern et al., 1986); negative controls were
unlabelled (Figure le,f). Extravillous cytotrophoblast in the
placental bed was also labelled by mAb5T4; no other
element of the term placenta was 5T4 antigen-positive.
Similar analysis of first trimester villous tissue revealed
antigen expression by both syncytiotrophoblast and cyto-
trophoblast (data not shown). The earliest stage examined
for 5T4 expression was in a chorionic villous biopsy at 9
weeks gestation which was positive by indirect immuno-
fluorescence (with Dr Bruce Smith, Jefferson, Philadelphia).
This level of analysis suggests that 5T4 antigenic molecules
are expressed by representatives of all subpopulations of
trophoblastic cells.
5T4 was unreactive with the following non-pregnant
tissues examined in immunohistology; spleen, heart, brain,
liver, lung, bronchus, skeletal muscle, testis or ovary.
Glomeruli in the kidney, villi of the small intestine, bladder
epithelium, basal layer of the epidermis, endometrial glands72kD TROPHOBLAST GLYCOPROTEIN 241
Figure 1 Expression of 5T4 antigen in placenta. Immunohistology of term chorionic villi (a, c,e) or amnio-chorion (b,d,f) with
normal mouse serum (e,f) or monoclonal antibodies 1D2 (a), H316 (b) or 5T4 (c,d) followed by rabbit anti-murine
immunoglobulin peroxidase conjugate. Sections were counterstained with haemalum. IVS, intervillous space; St, syncytio-
trophoblast; VS, villous stroma; AE, amniotic epithelium; AM, amniotic mesenchyme; CL, chorion laeve; DP, decidua parietalis.
5T4 shows specific labelling of villous trophoblast and extravillous cytotrophoblast of the chorion laeve as well as amniotic
epithelium. Positive control mAblD2 labels all cell types; mAbH316 labels trophoblast of the chorion laeve and amniotic
epithelium. Normal mouse serum shows no labelling.
of non-pregnant uterus and endocervical glands showed
some specific labelling with mAb 5T4. Some small vessels in
various tissues appeared to be weakly stained. Table I
summarises 5T4 reactivity assayed by immunohistology of
frozen tissue sections.
To further examine 5T4 expression, a semi-quantitative
assay of 5T4 antigen on isolated membranes of some of the
above tissues was assessed using solubilised proteins in an
immunodot assay. 5T4 was still reactive with full term
placental plasma membrane protein at an antigen concen-
tration of 50ng/dot. In contrast to the widely distributed
antigen recognised by mAb ID2, 5T4 was not specifically
reactive with any other tissue tested (ovary, testis, kidney,
brain, liver and muscle) at all antigen concentrations used
(up to 50,ug/dot). From this it was concluded that these
normal non-gestational tissues express 5T4 antigen at
- 1,000-fold lower concentration than full-term placenta on
a weight of crude membrane protein basis. This relative level
of expression is comparable with PLAP as measured using
mAbH317 (Table II).
Expression by cell lines
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Table I Reactivity of monoclonal antibody 5T4 with normal
human tissues assessed by immunohistology of frozen sections
Tissue Result
Placenta + + + Villous trophoblast and amnion
Brain -
Ovary -
Testis -
Skeletal muscle -
Heart -
Lung -
Bronchus -
Liver -
Spleen
Kidney + Glomeruli
Bladder + Epithelium
Small intestine + Villous epithelium
Uterus + Endometrial glands
Cervix + Endocervical glands
Skin + Basal epidermis
derivation was assessed by indirect immunofluorescence and
a more quantitative radiobinding assay (Table III). By
comparison of reactivity with negative control xenogeneic
cell lines, radiobinding indices of > 1.5 were considered to
indicate positive expression of antigen. Trypsinisation was
necessary to remove some attached cell lines from the
substratum and it was noted where compared that this
procedure tended to reduce the binding index compared with
EGTA removal (data not shown). Normal leukocytes were
5T4 antigen negative and 'normal' types represented by cell
lines of amnion, embryonic lung fibroblasts and embryonic
intestine origin were labelled by 5T4 antibodies. Tumour cell
lines of myeloid origin were all 5T4 antigen negative; 6/6
tumour cell lines of gestational or developmental origin were
positive. Eleven of 15 carcinomas of other histological types
and origins were positive, as was one glioma and 1/3 Wilms
tumour lines tested.
Immunoprecipitation
5T4 was unreactive with reduced and unreduced western
blots of StMPM. The molecular species bearing the 5T4
antigen was identified as a 72kD protein by reduced SDS-
PAGE analysis of immunoprecipitates from 1251-lacto-
peroxidase-labelled StMPM (Figure 2, lane 1). The molecules
migrate with a mol. wt of 69kD in unreduced SDS-PAGE.
It was observed that the relative mobility in SDS-PAGE
varies anomalously with the percentage of the acrylamide.
This is sometimes indicative of a glycoprotein, which is
confirmed by the change in mol. wt following removal of N-
linked sugars by digestion with N-glycanase, yielding a
molecule of 42kD (Figure 2, lane 2).
5T4 glycoprotein can be labelled by reduction with
tritiated sodium borohydride either after periodate oxidation
of sugar residues or galactose oxidase/neuraminidase treat-
ment. These latter treatments change the relative mobility
in SDS-PAGE as compared with 1251-labelled 5T4 antigen
(Figure 3). AV-3, Tera-2, MRC-5, Hep-2, HN5, HT29 cell
lines all express a molecule of similar mol. wt to that on
StMPM as judged by SDS-PAGE of immunoprecipitates
of surface iodinated cells; the antigen has been immuno-
precipitated from AV-3 cells metabolically labelled with
tritiated glucosamine (data not shown).
Gelfiltration
In order to investigate any association of 5T4 antigen with
itself or any other protein, DOC solubilised StMPM was
subjected to gel filtration over S200 Sephacryl run in the
presence of detergent, and the fractions assayed for 5T4
reactivity in ELISA. 5T4 antigen eluted with an apparent
Table II Expression of 5T4 and other trophoblast antigens
by non-pregnancy tissues assessed by immunodot
Immunodot titre
Tissue 5T4 H317 ID2
Term placenta 50ng 200ng 50ng
Brain >50pg >50pg 200ng
Muscle >50Qg >50 ig 200ng
Kidney >50pg >50pg 100ng
Liver >50pg >50,ug 100ng
Ovary >50,ug >50pg 100ng
Testis >50 ig >50 g 100ng
Results of immunodot expressed as minimum antigen
concentration required to produce a positive result.
mol. wt of 120kD, although there was a small peak of
reactivity in the void volume (Figure 4).
Antigenicity
Isolated StMPM membranes were digested- with trypsin,
pronase, neuraminidase or N-glycanase, the components
solubilised and subjected to immunodot assay. Both
proteases and N-glycanase destroyed 5T4 antigenicity, whilst
neuraminidase did not (Table IV). The effects of various
fixatives on 5T4 antigenicity as expressed by Tera-2 cells was
assessed by solid-phase radiobinding assay. Neither Bouins'
fixative, buffered formalin, gluteraldehyde nor absolute
ethanol were found to significantly affect 5T4 binding index
relative to PBS control (data not shown).
Discussion
5T4 antigen has a relatively limited tissue distribution. It
appears to be a pan-trophoblast marker which is expressed
by all types of trophoblast examined as early as 9 weeks of
development. It is specific for this tissue type within the
placenta except for the amniotic epithelium which is also
antigen positive. On the basis of immunoperoxidase staining
of frozen sections from normal tissue, 5T4 antigen is also
expressed by certain epithelial cell types. It should be noted
that several 'trophoblast-characteristic' antigens, such as
PLAP, are in fact found in normal tissues at trace concen-
trations (McLaughlin, 1986). Using a solid phase immuno-
assay to quantitate the expression of 5T4 relative to normal
tissue, 5T4 antigen was found in placental plasma membrane
in at least a 1,000-fold higher concentration than that found
in other normal tissues tested. However, this level of
sensitivity would not necessarily detect expression in minor
subpopulations of cells within a given tissue.
Several antibodies have exhibited a similar pattern of
reactivity with normal epithelial tissues, for example
HMFG1 and 2 (Taylor-Papadimitriou et al., 1981;
Wilkinson et al., 1984), and CA 1, 2 and 3 (Bramwell et al.,
1985), but this has not limited their use in immuno-
scintigraphy (Pateisky et al., 1985) or diagnosis of neoplasia
(Warr & Cruickshank, 1987). In this respect, 5T4 is reactive
with tumour cell lines of a diverse, but select origin,
including those of a developmental nature, such as chorio-
carcinoma and embryonal carcinoma. The reason for 5T4
antigen expression by cell lines of such apparent diversity of
tissue is not clear; the normal cell line types tested are all of
embryonic origin. The lack of reactivity with tumour cell
lines derived from lung, bronchus and lymphoid tissue is72kD TROPHOBLAST GLYCOPROTEIN 243
Table III Reactivity of mAb 5T4 with normal cells and transformed cell lines in cell-surface immunofluorescence and
radiobinding assay
Result
Fluor- Binding
Cell Origin Type escence index Reference
AV-3 Amnion Epithelial + 3.1 McLaughlin et al., 1982
WISH Amnion Epithelial nt (3.4) Gift of P. McLaughlin, Liverpool
MRC-5 Fibroblasts Embryonic + 3.8 t Jacobs et al., 1970
Flow7000 Fibroblasts Embryonic nt (2.9) Gift of P. McLaughlin, Liverpool
1407 Intestine Embryonic + nt Gift of A. Smith, Clatterbridge
PBL Peripheral blood Leucocytes - nt (1)
UC729/6 B-cell Myeloma - nt Gift of A. Smith, Liverpool
HMI B-cell Myeloma - nt Gift of A. Smith, Liverpool
RAJI B-cell Lymphoblastoid - 1.2 Pulvertaft, 1964
BSM B-cell Lymphoblastoid - 1.2 Gift of Dr C. Graham, Oxford
Daudi B-cell Burkitt's lymphoma - 1.2 Klein et al., 1967
B27 B-cell EBV-lymphoblastoid - 1.1 Gift of Prof. C, Hart, Liverpool
Molt-4 T-cell Leukaemia - nt Minowada et al., 1972
K562 T-cell Erythroleukaemia - 1.2 Andersson et al., 1979
GCCM/15 Brain Glioma + 5.2 t Gift of Dr T. Alderson, London
Hep-2 Larynx Carcinoma + (5.0) Moore et al., 1955
HN2 Larynx Carcinoma + (1.5)t Easty et al., 1981
HN4 Larynx Carcinoma + 3.0t Easty et al., 1981
HNI Tongue Carcinoma + 2.9t Easty et al., 1981
HN5 Tongue Carcinoma + 3.1 t Easty et al., 1981
IPT Bronchus Carcinoma - 1.2t Kumar et al., 1983
IPTV2 Bronchus Carcinoma 1.3 t Walker et al., 1984
N417 Small lung Carcinoma - 1.2 Gift of Dr T. Alderson, London
6CT Cervix Carcinoma + 2.2 Daniels et al., 1984
ElCo Breast Carcinoma nt 1.7 Gift of P. McLaughlin, Liverpool
EJ Bladder Carcinoma + nt O'Toole, et al., 1983
A431 Vulva Carcinoma + 4.2t Fabricant et al., 1977
HT29 Colon Carcinoma + 3.4t Gift of A. Smith, Liverpool
Mawi Colon Carcinoma - nt Gift of A. Smith, Liverpool
Chang Liver Carcinoma nt (4.1) Gift of P. McLaughlin, Liverpool
Tera-1 Testis Teratocarcinoma + (2.6) Fogh and Trempe, 1975
Tera-2 Testis Teratocarcinoma + 4.2 Thompson et al., 1984
2102Ep Testis Teratocarcinoma + (3.5) Andrews et al., 1984
PA-I Ovary Teratocarcinoma + (4.1) Zeuthen et al., 1980
BeWo Chorion Choriocarcinoma + (5.2) Patillo and Gey, 1968
JAr Chorion Choriocarcinoma + (4.9) Patillo et al., 1971
SK-NEP Kidney Wilm's tumour - (1.2) Fogh and Trempe, 1975
Gos.1.8.1 Kidney Wilm's tumour (1.4) Gift of Dr C. Graham, Oxford
GM3808 Kidney Wilm's tumour + (5.1)t Gift of Dr T. Alderson, London
Cells harvested with EGTA alone or EGTA-trypsin (t). Cells incubated with mAb5T4 followed by fluorescein-conjugated
sheep anti-murine Ig (immunofluorescence) or 1251 rabbit anti-mouse immunoglobulin (Binding assay). Results expressed as
positive immunofluorescence or binding index relative to negative control. Standard deviation of 4 replicates was < 10%;
variation between 2-4 experiments was generally < 10%. Figures in parentheses represent results from a single experiment.
(1) PBL isolated from peripheral blood by centrifugation over Ficoll-hypaque. nt=not tested.
consistent with the immunohistology of the normal tissue
types. Other antigen positive tumour cell lines may have
been derived from an epithelial component of normal tissue
or represent re-expression of embryonic antigen on tumour
cells. Several trophoblast antigens have been reported to
exhibit a pattern of expression by tumour cell types
apparently not detected in the normal cell counterpart
(McLaughlin et al., 1982). In the study by Rettig et al.
(1985), a series of six monoclonal antibodies were generated
against choriocarcinoma cells, one of which was reactive
with neoplastic, but not normal, kidney cells; the other
mAbs did not demonstrate such a selective expression.
Several trophoblast associated antigens have been reported
in the literature to be expressed on tumour cell lines. 5T4
antigen does, however, appear to be novel. On the basis of
reactivity in dot-blots and other criteria, we have specifically
excluded PLAP and transferrin as the 5T4 antigen. On the
basis of mol. wt in reduced gels, we have further excluded
transferrin receptor (Trowbridge et al., 1984), insulin
receptor (Ullrich et al., 1985), EGF receptor (Waterfield et
al., 1982), HMFGI and 2 (Burchell et al., 1983), CA
(Wiseman et al., 1984), CEA (Krantz et al., 1979), alpha
foeto-protein (Ruoslahti, 1979) and all of the placental
specific proteins reviewed by Bohn et al. (1983). On the basis
of mol. wt and cell line reactivity, none of the monoclonal
antibodies described by Lipinski et al. (1981), Sunderland et
al. (1981), McLaughlin et al. (1982), Loke et al. (1984),
Travers and Bodmer (1984), Rettig et al. (1985), Yamashita
et al. (1986) or Mueller et al. (1986) appear to recognise this
antigen.
The 5T4 antigen is carried by glycoprotein molecules of
72kD on syncytiotrophoblast microvillous plasma
membranes but appears on molecules of similar mol. wt
from several different cell lines including some chorio-
carcinomas. The molecules are sialylated and have
approximately 30kD of the apparent mol. wt due to N-
linked carbohydrate structures as judged from removal of
the latter by N-glycanase endoglycosidase.
5T4 appears to exist on the cell surface as a monomeric
protein. Firstly, 5T4 antigen elutes with an apparent mol. wt
in gel filtration of 120kD, an increase consistent with the
addition of a detergent shell, and inferring that 5T4 is not
associated non-covalently with any other large molecules.
Additionally, reduction with 2-mercaptoethanol does not
substantially alter the apparent mol. wt of the 5T4 radio
immunoprecipitate, as would be the case if it were disulphide
bonded to another protein.
The pattern of expression of 5T4 is similar to that of the244 N. HOLE & P.L. STERN
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Figure 2 Immunoprecipitation of 5T4 molecules from StMPM.
Autoradiography of SDS-PAGE analysis of 5T4 immuno-
precipitates of NP-40 solubilised 125I-lactoperoxidase labelled
StMPM (lane 1) and following digestion with N-glycanase (lane
2). 8% gel.
T Pi GO-N
-93
-69
-46
Figure 3 Fluorography of reduced SDS-PAGE of 5T4 immuno-
precipitates from StMPM labelled with NaB3H4 following
treatment with either periodate (PI) or galactose oxidase and
neuraminidase (GO-N). 10% gel. T is total radiolabelled glyco-
protein following periodate treatment.
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Figure 4 Gel filtration of 5T4 antigenic molecules. Solubilised
StMPM protein fractionated over S200 Sephacryl in the presence
of detergent. Fractionated 5T4 antigenicity assessed in ELISA
family of mucin type glycoproteins (Swallow et al., 1987),
but with clear differences from those defined by the CA or
HMFG series of antigens (Wiseman et al., 1984; Burchell et
al., 1983). These latter glycoproteins are defined by several
monoclonal antibodies which have been shown to be reactive
with a wide range of malignant tumour cells but also
reactive with certain specialised normal epithelia.
The limited tissue distribution and expression by selected
tumour cell lines encourages further studies on the
expression of 5T4 antigen by solid tumours of diverse origin.
Analysis of primary tumour material from a variety of
neoplasms has revealed specific staining of some different
tumours (Southall, Boxer, Bagshawe et al., in preparation).
The 5T4 antigenicity appears to depend on both protein and
carbohydrate structures but studies using a radiobinding
assay with a teratocarcinoma cell line suggested that fixation
procedures do not destroy 5T4 antigenicity. Thus immuno-
histological analysis of 5T4 may be possible using fixed and
embedded material.
Table IV Effect of enzymic
digestion on 5T4 antigenicity assessed
in immunodot
5T4
Enzyme titre
PBS 80ng
Pronase >10 ug
Trypsin > 10pg
Neuraminidase 80ng
N-glycanase > 10pg
StMPM protein incubated
overnight at 37°C with appropriate
enzymes or PBS (as control for auto-
degradation) and dot-blotted onto
nitrocellulose. Results expressed as
minimum protein dot concentration
required to produce a positive result.
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